Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report. Academic Article uri icon

Overview

abstract

  • Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white female with ANCA positive pulmonary hemorrhage who was treated with cyclophosphamide (CYC) and rituximab (RTX) combination therapy.

publication date

  • October 27, 2011

Research

keywords

  • Journal Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3215638

Digital Object Identifier (DOI)

  • 10.1186/1546-0096-9-33

PubMed ID

  • 22032441

Additional Document Info

start page

  • 33

volume

  • 9

number

  • 1